Guest Column: The Eight Billion Opportunity!  |  Finance: Covidonomics   |  Parent Interventions: Enrichment programmes help children build knowledge  |  Parent Interventions: Half of moms-to-be at risk of preeclampsia are missing out on preventive aspirin  |  Parent Interventions: First month of data shows children at low risk of COVID-19 infection  |  Teacher Insights: First-generation learners being left behind in global education  |  Teacher Insights: Deep learning: A new engine for ecological resource research  |  Parent Interventions: Study compares the health of Irish children to those across Europe and Canada  |  Policy Indications: MHRD ensures safe shifting of stranded students of Jawahar Navodaya Vidyalayas  |  National Edu News: RNA extraction kit Agappe Chitra Magna launched commercially  |  National Edu News: Certifying Quantum Entanglement: A step towards Quantum Security  |  Leadership Instincts: IIT Guwahati discovers new ways to prevent memory loss due to Alzheimer  |  Teacher Insights: 82 UG and 42 PG Non-Engineering MOOCs to be offered on SWAYAM  |  International Edu News: Handwashing 6-10 times a day linked to lower infection risk  |  Leadership Instincts: Bristol’s photon discovery, a major step toward large-scale quantum technologies  |  
April 04, 2020 Saturday 08:57:59 PM IST

CSIR-IMTECH takes up sample testing for Covid-19

Leadership Instincts

 Council of Scientific and Industrial Research-Institute of Microbial Technology (CSIR-IMTECH) has stepped up to take up Covid-19 sample testing. This is in line with the directives issued by the Principal Scientific Adviser (PSA) to the Government of India and the advisory issued by the Indian Council of Medical Research (ICMR) to operationalise Covid-19 testing by laboratories under CSIR and other labs affiliated to Department of Science and Technology (DST), Department of Biotechnology (DBT) and Department of Atomic Energy (DAE).

“The initiative of ICMR to involve all government-accredited labs is a welcome step and will be a game changer in testing of Covid-19 samples. This would increase the testing rate among suspected patients. In the initial phase, IMTECH plans to operationalise capabilities to carry out testing of 50 to 100 samples a day, which can be subsequently ramped up as and when required,” said DrSanjeev Khosla, Director, IMTECH, Chandigarh.

The institution has augmented its capabilities to carry out clinical testing for COVID-19 and has the necessary expertise in molecular microbiology. The lab has the requisite infrastructure including Biosafety Level (BSL)-3 facility as the labs are advised to take all appropriate biosafety and bio-security precautions before testing. A newly constructed BSL-2+ virology lab equipped with Reverse Transcription Polymerase Chain Reaction (RT-PCR) equipment has also been established. All the mandatory approvals required for testing of clinical samples have been obtained to operationalise testing at the earliest.

Apart from testing of clinical samples, CSIR-IMTECH is also supporting healthcare professionals by providing Personal Protection Equipment (PPE) to prevent them from contracting any infection while serving patients. The institute is also extending help to the local administration and Red Cross Unit of Chandigarh by providing the logistical and infrastructure support.


Comments